MAG-182

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMAG-182
Drug Alias NameMAG-182MAG-181
ClassificationSmall molecules
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFlorida State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFlorida State University
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A